Profile

Profile – Dr Hazel Hall-Roberts

Name:

Dr Hazel Hall-Roberts

Job title:

Postdoctoral Research Scientist

Place of work / study:

Sir William Dunn School of Pathology & Alzheimer’s Research UK Oxford Drug Discovery Institute

Area of Research:

Neuroinflammation

How is your work funded:

Funded by Alzheimer’s Research UK Oxford Drug Discovery Institute

Tell us a little about yourself:

I first got excited about microglia and Alzheimer’s disease when I was an undergraduate studying biochemistry at the University of Bristol. I had a really fantastic Year in Industry working at GSK (Epinova DPU in Stevenage) on acute inflammation of macrophages, and I also had a life-long interest in neuroscience, which ultimately propelled me into the arms of neuroinflammation research! My PhD work at the University of Bath was actually a small side-step, working with neuronal cell lines to explore potential indirect interactions between the two neurodegenerative disease proteins amyloid-beta and alpha-synuclein. It was all good experience, and I ended up with my dream postdoc job at the University of Oxford, where I have been using stem cell models of microglia to study an Alzheimer’s disease-linked mutation in the gene TREM2, and developing tools and assays to study their behaviour in the dish. My postdoc is a collaboration between the ARUK ODDI and Dr Sally Cowley at the Sir William Dunn School of Pathology. On the ARUK ODDI side, I primarily work with Dr Emma Mead and her neuroinflammation team.

Tell us a fun fact about yourself:

Not many people know this, but I was awarded a black belt in Wado-Ryu karate when I was 16!

Why did you choose to work in dementia?

I can’t remember making a conscious decision to work on dementia, but I’m sure that Oliver Sacks had a bit to do with it – as an undergrad I read “The Man who Mistook his Wife for a Hat” and was absolutely enthralled by neurological diseases. The cases in his book are exceedingly rare, but unfortunately Alzheimer’s disease is anything but rare- so many people are affected by it and so little can be done to manage the condition. I would love to be in the generation of scientists that collectively finds one or more drugs that halt progress of the disease in patients.

Can we find you on Twitter?

Leave a Reply